Batch documentation should be reviewed before laboratory use
When someone first starts treatment with a GLP-1 receptor agonist, we slowly introduce the medication for a reason theres a risk of gastrointestinal side effects as your body gets used to the drug
Suppresses Glucagon Secretion: It also acts on the alpha cells of the pancreas to reduce the secretion of glucagon, a hormone that tells the liver to release stored glucose
Ozempic is FDA-approved specifically for the treatment of type 2 diabetes but is commonly prescribed off-label for weight management
GLP-1 are transforming lives, yet lasting success depends on more than just the prescription
In the phase 2 dose-escalation study (Jastreboff et al., NEJM, 2023), gastrointestinal adverse events were reported in a substantial proportion of participants, with incidence increasing at higher doses